With telehealth surging around the globe due to the COVID-19 pandemic, the UK National Health Services has released guidance that provides a set of good practice principles for third-party partners to follow....more
2/5/2021
/ Coronavirus/COVID-19 ,
Data Protection ,
Electronic Protected Health Information (ePHI) ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Infectious Diseases ,
Life Sciences ,
Patient Access ,
Personal Data ,
Regulatory Agenda ,
Telehealth ,
Telemedicine ,
UK
Welcome to the third issue of our European Life Sciences Review that covers some of the most critical developments in the pharmaceutical and medical technology sectors in the last month and is produced by our life sciences...more
7/16/2016
/ Anti-Competitive ,
Anti-Corruption ,
Clinical Trials ,
Data Protection ,
EU ,
EU-US Privacy Shield ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Medical Devices ,
Mobile Health Apps ,
Off-Label Promotion ,
Pharmaceutical Industry ,
TTIP ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA)
Welcome to the first issue of our EU Life Sciences Review . It is produced by our life sciences lawyers in London, Brussels, Frankfurt, Moscow, and Paris and covers some of the most critical developments in the pharmaceutical...more
2/2/2016
/ Biotechnology ,
EU ,
European Commission ,
European Court of Justice (ECJ) ,
European Food Safety Authority (EFSA) ,
General Data Protection Regulation (GDPR) ,
Hazardous Waste ,
Life Sciences ,
Orphan Drugs ,
Personalized Medicine ,
The Patent Box ,
UK ,
Unitary Patent ,
US-EU Safe Harbor Framework